Veterinary medicine has long operated on a “one-size-fits-all” model: two dogs of the same breed with the same diagnosis typically receive the same drug, at the same dose, following the same protocol. That model is changing, and veterinary diagnostic laboratories are at the center of the shift. As genetic testing becomes more accessible and affordable, referring veterinarians and breeders are asking labs to screen an individual animal’s DNA, the genetic blueprint that shapes how that particular patient responds to disease, medication, and treatment.
This shift toward personalized veterinary medicine mirrors what has already happened in human diagnostics, where genomic testing labs routinely support cancer treatment selection, drug safety screening, and preventive care. For veterinary laboratories, the same principles are opening up a fast-growing service line: predicting inherited disease risk, supporting proactive wellness screening, and generating the tumor-level data that drives targeted therapy in conditions like canine cancer. Capturing that opportunity depends heavily on how efficiently a lab can manage the sample intake, testing workflows, and data output involved, which is where a cloud-based laboratory information management system (LIMS), becomes core infrastructure rather than a back-office convenience.
How Genetic Testing Fits Into the Modern Veterinary Laboratory
Genetic testing begins with a small DNA sample, most often a cheek swab or blood draw, submitted to a laboratory for screening against specific mutations, gene variants, or broader mutation panels. Depending on the assay menu a lab offers, this can range from targeted polymerase chain reaction (PCR) assays built around a single, well-characterized mutation to next-generation sequencing (NGS) panels capable of screening dozens of genes, or an entire tumor’s mutation profile, in a single run.
For veterinary laboratories, this represents a shift in both workflow and value proposition, not just a new test on the menu. Rather than processing samples solely to confirm or rule out an existing clinical suspicion, labs are increasingly generating data that referring veterinarians and breeders use proactively, to flag risk before disease onset or guide drug selection before a prescription is written. That shifts what a genetic testing service needs to deliver: results often have to be interpreted against breed-specific variant frequencies, linked across related animals for lineage tracking, and reported in a format referring vets can act on with confidence, not just a raw positive or negative call.
This is a meaningful departure from a lab’s traditional diagnostic workload, which has largely centered on chemistry panels, hematology, and pathology performed after a problem has already emerged. Genomic testing adds a new category of specimen, assay, and data complexity to the menu, one that demands longer sample and data retention, careful variant interpretation, and reporting workflows built for genetic nuance rather than a single reference range.
Genetic Testing Services For Modern Vet Labs
Drug Sensitivity and Pharmacogenomics Panels
Pharmacogenomics, the study of how an individual’s genetic makeup influences their response to drugs, is one of the most in-demand additions to a veterinary lab’s genetic testing menu. A well-known example is the multidrug resistance 1 (MDR1) gene, also referred to as ABCB1, common in herding breeds such as Collies, Australian Shepherds, and Shetland Sheepdogs. Dogs carrying a mutation in this gene have impaired function of P-glycoprotein, a protein that normally keeps certain drugs out of the brain, leaving affected dogs prone to severe, sometimes fatal, neurotoxic reactions to standard doses of common parasiticides, anesthetics, and chemotherapy agents.
For a lab, offering an MDR1 assay is a relatively contained way to enter pharmacogenomic testing: it is a single, well-validated target with clear clinical utility, and demand is steady given that, in some herding breeds, as many as seven out of ten tested dogs carry at least one copy of the mutated gene. Broader pharmacogenomic research is expanding into other therapeutic areas as well, including cardiology, where specific gene variants have been linked to individual response to common cardiovascular drugs. Labs that build validation and reporting processes around a single high-confidence marker like MDR1 are often well positioned to expand into broader pharmacogenomic panels as clinical demand grows.
Oncology Genomic Profiling
Cancer remains one of the leading causes of death in dogs, and tumor genomic profiling has become one of the fastest-growing referral categories for labs offering NGS-based testing. Instead of a single marker, oncology panels typically screen a tumor sample against a broad list of known cancer-associated genes, generating a mutation profile that referring oncologists use to select targeted therapies rather than defaulting to a standard chemotherapy protocol.
The clinical yield can be substantial: recent research examining genomic alterations across dozens of canine cancer types found that nearly nine out of ten tumors carried at least one mutation with diagnostic, prognostic, or therapeutic relevance. For a lab, that translates into a high “hit rate” on actionable results, but also more operational complexity than a single-target test. Labs need validated bioinformatics pipelines to call variants accurately, a process for annotating clinical relevance as the biomarker literature evolves, and a reporting format that condenses a large volume of genomic data into something a referring veterinarian can act on.
Predictive Disease Screening Panels
Many inherited conditions in companion animals develop gradually and are difficult to catch early using physical exams alone, which makes them well suited to laboratory-based screening rather than reactive testing. Degenerative myelopathy, a progressive spinal cord disease affecting mobility in older dogs, is a good example: the condition is strongly associated with a mutation in the SOD1 gene, and a validated assay allows labs to flag at-risk dogs well before referring veterinarians see clinical signs such as hind-limb weakness.
This kind of panel tends to work best as a standing service offered through wellness or breed-specific testing programs, since demand is often driven by breeders and preventive-care-focused practices rather than a single diagnostic workup.
Breeder and Inherited Disease Panels
Genetic testing has become an important recurring revenue stream for laboratories serving breeding programs. By offering panels that screen breeding animals for known disease-causing mutations, labs give breeders the data needed to make informed pairing decisions and reduce the likelihood of passing on heritable conditions to future litters, particularly for autosomal recessive conditions where two carrier parents, each outwardly healthy, can still produce affected offspring.
Because breeder testing often involves multiple related animals tested over years, this segment places a premium on a lab’s ability to track lineage and link results across generations, not just report a single animal’s genotype. Population-level data suggests that widespread adoption of this kind of testing can meaningfully shift the genetic profile of a breed over a relatively short period of time, as breeders increasingly avoid pairings that would concentrate risk alleles, which tends to drive sustained, repeat testing volume for labs that serve this market well.
Operational Challenges Labs Should Plan For
Despite the growth opportunity, scaling genetic testing is not without complications for a laboratory. Unlike human genetic testing, which benefits from extensive regulatory oversight and standardized clinical guidelines, many veterinary genetic tests are developed and offered with varying levels of validation. Labs need rigorous internal validation processes and clear documentation of assay performance, since referring clinicians rely on lab-reported results to make treatment and breeding decisions.
There is also growing recognition that generating genetic data is only useful if a lab can interpret and communicate it effectively. This has fueled interest in more structured genetic counseling support attached to laboratory results, helping translate raw genotype data into clear, actionable guidance for referring veterinarians and breeders. As panels grow larger and testing volume increases, labs need reliable systems to manage this information without losing traceability, introducing transcription errors, or creating reporting bottlenecks that slow turnaround time.
The Role of a Cloud-Based Veterinary LIMS Software
As genetic testing volume grows, laboratories need infrastructure that can keep pace with larger sample loads, more complex test menus, and stricter expectations around data integrity. A cloud-based Vet LIMS provides a centralized platform to manage the entire testing workflow while supporting the unique requirements of veterinary genetic testing.
Key veterinary LIMS software capabilities include:
- Centralized sample management from accessioning through testing, review, and reporting, with a complete chain of custody for every specimen.
- Integration with genomics testing instruments, including Next-Generation Sequencing (NGS) platforms, PCR systems, and DNA sequencers, to automate data capture, eliminate manual data entry, and improve workflow efficiency.
- Species-, breed-, and age-specific reference ranges that apply appropriate test limits and automatically flag abnormal results.
- Genealogy and lineage tracking to link related samples and historical results, supporting breeding and hereditary disease programs.
- Built-in audit trails, electronic signatures, and role-based access to help laboratories maintain regulatory compliance and stay audit-ready.
- Secure web portals for veterinarians and animal owners to view, download, and share test reports, monitor sample status, and access historical results while ensuring data privacy and controlled access.
- Automated result validation and configurable report templates to improve consistency while reducing manual review and transcription errors.
- Equipment calibration tracking to help ensure instruments remain compliant and testing quality is maintained.
- Centralized management of genomic testing data, making it easier to handle the large datasets generated by sequencing and PCR-based assays without relying on spreadsheets or disconnected systems.
- Automated integration of genomic test results with patient records, enabling seamless consolidation of sequencing data, variant interpretations, and laboratory findings into a single, searchable repository.
By streamlining laboratory operations and consolidating data into a single platform, a cloud-based veterinary LIMS software enables veterinary genetics laboratories to scale efficiently, improve data integrity, and spend more time on testing and interpretation rather than administrative tasks.
Conclusion
Genetic testing is steadily reshaping what veterinary diagnostic laboratories are asked to deliver, moving demand away from single-purpose diagnostic panels and toward services built around an individual animal’s genetic profile. From pharmacogenomic screening that flags drug sensitivities before a prescription is written, to oncology panels that match cancer treatment to a tumor’s specific mutations, to predictive and breeder screening that catches inherited conditions long before symptoms appear, the case for building out a genetic testing menu is difficult to ignore. Capturing that opportunity depends on more than assay development; it also requires the infrastructure to manage sample volume, data complexity, and reporting accuracy at scale. Labs that pair a well-designed genetic testing menu with the right systems, including a well-implemented cloud-based vet LIMS, will be best positioned to serve referring veterinarians and breeders as personalized veterinary medicine moves from niche offering to standard of care.